Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin

Hideharu Hagiya, Hiroki Kajioka

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We herein report the case of an 85-year-old woman presenting with right internal jugular vein candidal thrombophlebitis associated with central venous catheters (CTCVC). The infecting agent was Candida albicans, which caused recurrent candidemia five times in total. Micafungin (MCFG) alone was ineffective; however, the combination of MCFG with fosfluconazole (F-FLCZ) successfully treated the patient without a need for any anticoagulant or surgical therapies. To the extent of our knowledge, this is the first report of CTCVC being successfully treated with a combination of F-FLCZ and MCFG. These new antifungal agents have better efficacy, tolerability and bioavailability; therefore, they can be useful alternatives to classical combination therapies such as amphotericin-B and 5-fluorocytosine.

Original languageEnglish
Pages (from-to)2139-2143
Number of pages5
JournalInternal Medicine
Volume52
Issue number18
DOIs
Publication statusPublished - Sep 24 2013
Externally publishedYes

Fingerprint

Candidemia
Thrombophlebitis
Central Venous Catheters
Flucytosine
Antifungal Agents
Jugular Veins
Amphotericin B
Candida albicans
Anticoagulants
Biological Availability
Therapeutics
micafungin
fosfluconazole

Keywords

  • Candidemia
  • Fluconazole
  • Micafungin
  • Thrombophlebitis

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{54f810b2d442439eb86488e8eb933fa1,
title = "Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin",
abstract = "We herein report the case of an 85-year-old woman presenting with right internal jugular vein candidal thrombophlebitis associated with central venous catheters (CTCVC). The infecting agent was Candida albicans, which caused recurrent candidemia five times in total. Micafungin (MCFG) alone was ineffective; however, the combination of MCFG with fosfluconazole (F-FLCZ) successfully treated the patient without a need for any anticoagulant or surgical therapies. To the extent of our knowledge, this is the first report of CTCVC being successfully treated with a combination of F-FLCZ and MCFG. These new antifungal agents have better efficacy, tolerability and bioavailability; therefore, they can be useful alternatives to classical combination therapies such as amphotericin-B and 5-fluorocytosine.",
keywords = "Candidemia, Fluconazole, Micafungin, Thrombophlebitis",
author = "Hideharu Hagiya and Hiroki Kajioka",
year = "2013",
month = "9",
day = "24",
doi = "10.2169/internalmedicine.52.0584",
language = "English",
volume = "52",
pages = "2139--2143",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "18",

}

TY - JOUR

T1 - Successful treatment of recurrent candidemia due to candidal thrombophlebitis associated with a central venous catheter using a combination of fosfluconazole and micafungin

AU - Hagiya, Hideharu

AU - Kajioka, Hiroki

PY - 2013/9/24

Y1 - 2013/9/24

N2 - We herein report the case of an 85-year-old woman presenting with right internal jugular vein candidal thrombophlebitis associated with central venous catheters (CTCVC). The infecting agent was Candida albicans, which caused recurrent candidemia five times in total. Micafungin (MCFG) alone was ineffective; however, the combination of MCFG with fosfluconazole (F-FLCZ) successfully treated the patient without a need for any anticoagulant or surgical therapies. To the extent of our knowledge, this is the first report of CTCVC being successfully treated with a combination of F-FLCZ and MCFG. These new antifungal agents have better efficacy, tolerability and bioavailability; therefore, they can be useful alternatives to classical combination therapies such as amphotericin-B and 5-fluorocytosine.

AB - We herein report the case of an 85-year-old woman presenting with right internal jugular vein candidal thrombophlebitis associated with central venous catheters (CTCVC). The infecting agent was Candida albicans, which caused recurrent candidemia five times in total. Micafungin (MCFG) alone was ineffective; however, the combination of MCFG with fosfluconazole (F-FLCZ) successfully treated the patient without a need for any anticoagulant or surgical therapies. To the extent of our knowledge, this is the first report of CTCVC being successfully treated with a combination of F-FLCZ and MCFG. These new antifungal agents have better efficacy, tolerability and bioavailability; therefore, they can be useful alternatives to classical combination therapies such as amphotericin-B and 5-fluorocytosine.

KW - Candidemia

KW - Fluconazole

KW - Micafungin

KW - Thrombophlebitis

UR - http://www.scopus.com/inward/record.url?scp=84884340517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884340517&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.52.0584

DO - 10.2169/internalmedicine.52.0584

M3 - Article

C2 - 24042529

AN - SCOPUS:84884340517

VL - 52

SP - 2139

EP - 2143

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 18

ER -